DrRobertFoxUtahSSF

Current issues in the Diagnosis and Management of Sjogren’s Syndrome Robert I. Fox, MD., Ph.D. Scripps Memorial Hospital And Research Institute La Jolla, CA [email_address]

Primary Sjogren A systemic autoimmune disease whose characteristic is ocular and salivary involvement, but also includes other organs such as lung (pneumonitis), kidney (interstitial nephritis), and neurological (central and peripheral) and lymphoproliferative features

Correct therapy depends on correct diagnosis New international criteria Potential pitfalls in diagnosis Goal-1

Goals-2 Review the use of Topical medications for dry eyes and dry mouth

Goals-3 Review the current guidelines for diagnosis and therapy of extra glandular manifestations

Goals-4 How to empower the patient to participate in their own care

Epidemiology of Sjogren’s Predominately women (9:1) with two ages of median onset In the 30’s and 50’s 2. Much of what we call SLE in the older patient is actually Sjogren’s syndrome

What causes Sjogren’s A combination of Genetic and Environmental Factors From family and twin studies, approximately 4 genes are required but even then an environmental factor is needed

Genetics Most important is HLA-DR, which correlates closely with ANA and anti-SS-A antibody Genes of B-cell activation similar to SLE patients

Environmental No single agent identified Viral candidates may include EBV and coxsackie viruses Hepatitis C, HIV and HTLV-1 can mimic

There is good agreement about diagnosis for the patient with florid symptoms of keratoconjunctivitis sicca (KCS), parotid swelling, and high titer ANA with SS-A/SS-B. The issue in these patients will be therapy And the extent of extra glandular involvement. Objective-1 Clinical Issues

Typical features of dry eyes, dry mouth and swollen glands

Dryness results in the clinical appearance of keratoconjunctivitis sicca (KCS) characteristic of Sjogren’s syndrome

Severe Xerostomia with dry tongue

Sjogren’s syndrome Eye and Oral Features Most of these patients have a positive ANA with positive Anti-Sjogren’s SS-A/SS-B antibodies 2. They have specific needs for the eye and mouth care

Since these patients see many health care professionals (ophthalmologists, dentists, rheumatologists) their care is expensive and fragmented We must empower them to be part of the therapeutic team and even to educate their health providers

Sjogren’s Syndrome- Cervical Dental Caries

In addition to dry eyes and dry mouth These patients have signs and symptoms that affect other parts of their body ranging from obvious manifestation of skin vasculitis to vague symptoms of fatigue and cognitive loss

Diagnostic Issues In the patient with true Sjogren’s Sjogren’s syndrome Extent Of Extra glandular Disease Therapy And Education

Differential Diagnosis: is the Dryness Due to Other Causes Non Salivary Gland Disease Drugs-esp.. BP and cardiac muscle relaxants antidepressants and OTC meds for cold Acute anxiety and depression Mouth breathing Central lesions: Multiple sclerosis Alzheimer’s Salivary Gland Disease Hepatitis C Sarcoidosis Fatty Infiltrate of Gland HIV disease Lymphoma Cancer of the Salivary Gland Infection of gland (TBC, Actinomycosis) Head & neck radiotherapy

The most difficult and common questions involve the diagnosis and treatment of the patients with vague complaints of dryness, fatigue, cognitive dysfunction, arthralgias and low titer ANA Objective-2 Clinical Issues

Objective-3 Clinical Issues of Diagnosis of fatigue Primary Sjogren’s (high ESR, CRP) Hypothyroid Drug toxicity Sleep disorder (nocturnal myoclonus) Fibromyalgia with Low titer ANA and depression

Issues in Diagnosis-1 Past confusion over criteria San Diego criteria (0.5% incidence) versus Original EEC criteria (5% incidence) Now clarified With new proposed international criteria

Issues in Diagnosis-2 Submitted criteria (11/01) by International SS advisory board Will require either A positive minor salivary gland biopsy Or Antibody against SS-A (Ro)

New international criteria-1 1. Ocular Symptoms 2. Oral Symptoms 3. Salivary gland function (flow rate by flow rate, scan, or sialography) AND 4. Histopathology (focus score > 1) 5. Autoantibody to SS-A or SS-B

New international criteria-2 New Criteria for SS (cont’d) Exclusions Pre-existing lymphoma, sarcoid Hepatitis B or C Drugs with Anticholinergic side effects (measurements of tear/saliva with patient off drug for 3 half lives)

Caution in interpreting studies on clinical associations published during past several years-since results will depend on the inclusion criteria For example: A) On disease associations (esp. liver-as hepatitis C now now an exclusion) B) “Primary” Fibromyalgia patients now excluded

How good are our tests? The lip biopsy and the the ANA and anti-SS A antibody are often considered “specific” tests but they are not specific

Pitfalls in diagnosis-1 A) Positive ANA does not mean Sjogren’s or SLE These tests are sensitive but not specific (only about 1:100 patients with ANA 1:320 will have SS or SLE) B) anti SS-A antibody more specific-but differences between detection kits

The ANA is sensitive but not specific The ANA should not be used as a screen for Sjogren’s or SLE but to confirm a clinical diagnosis ANA 1:80 present in 20% of normals (esp. in fibromyalgia patients) This is important since some aggressive physicians have actually treated fibromyalgia patients for their fatigue with cyclophosphamide thinking that it was CNS vasculitis

On review of outside biopsies diagnosed as Sjogren’s syndrome, over half (32/60) were reclassified on review. Vivino, F.B., I. Gala, and G.A. Hermann, Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol, 2002. 29 (5): p. 938-44. Even the Gold standard of lip biopsy is often misread by pathologists

Part of the confusion is that patients complain of dry eyes/mouth and rheumatologists talk about antibodies Why do patients complain of dry eyes and dry mouth? It is important to recognize that symptoms can only be interpreted as part a functional unit that involves a neuroendocrine circuit

They are describing the sensation of increased friction As the eyelid traverses the orbit Or the tongue moves around the buccal mucosa

Normally the upper eyelid glides over the globe on a coating called the tear film composed of water, protein, mucins orbit eyelid Tear film

When the tear film is inadequate, The upper lid sticks to the surface of the orbit and Actually pulls of the surface layer of the ocular surface orbit eyelid Tear film The Sjogren’s patient is describing increased friction as the upper lid moves over the globe

In Sjogren’s syndrome A similar deficiency in the saliva increases the friction as the tongue moves around the mouth in order to swallow or talk The decrease in saliva leads to acceleration of dental decay and other infections such as oral candidiasis

The Sjogren’s Syndrome with swollen parotid gland The concern is infection or lymphoma

Sjogren’s Syndrome - Diffuse Submandibular Salivary Gland Enlargement

Sjogren’s Syndrome - Ascending Salivary Gland Infection

Sjogren’s Syndrome - Investigations MRI

If you order an MRI Ask for MRI -sialography (this is just a fat suppression view to visualize the ducts). It takes only 5 minutes more and no risk Have the MRI printed out on CD and give copy to patient for their record

Although the systemic manifestations can occur in Sjogren’s as in SLE, there are some subtle differences

Extraglandular manifestations Sjogren’s syndrome Skin-hyperglob purpura……. Lung-interstitial pneumonitis Renal-interstitial nephritis… Cardiac-pulmonary hypertension.. Hematologic--lymphoma…. Neurologic-peripheral neuropathy Esophageal-dysphagia and tracheal reflux SLE Skin-leukocytoclastic vasculitis Lung-pleural effusions Renal-glomerulonephritis Cardiac-pericarditis Hematologic-ITP, hemolytic anemia Neuropathy-mononeuritis multiplex

Systemic therapy-1 In general, similar to SLE Steroids work and the question is how to get the patients off steroids

Systemic therapy-2 Usually start with hydroxychloroquine or methotrexate for rash or arthralgias

Systemic therapy-3 For severe visceral vasculitis, still use cyclophosphamide (pulse) But try to use less than 6 cycles and then try Leflunomide, mycophenolic acid anti-CD20 (Rituxin)

Systemic therapy-4 Recent preliminary report that infliximab (Remicade) Published (Steinberg, 2003) But a larger multicenter trial Presented at American College of Rheumatology Did not show benefit of TNF inhibitor

How can we educate and make the patient part of the therapeutic team In an era of decreased time for patient contact, we must utilize the internet and support groups as a backbone. The internet can be source of either information or mis-information unless we help create useful sites.

What should be on an Internet site? We need to ask Patients what they want and need- medications and procedures insurance issues c) Hot “Links” to other relevant sites

But not all patients are computer literate? Determine if physicians and patients can work through local libraries, where high school students can fulfill “civic service” by setting up sites and serving as resources to maintain sites.

Summary-1 New diagnostic criteria are developed that should diminish confusion in clinical practice and in the research literature There is variability in reading minor salivary gland biopsies and interpretation of positive ANA’s

Sjogren’s syndrome has clinical features and treatment that are generally similar to SLE But the Sjogren’s patient has particular needs in terms of the medications they tolerate and particular disease manifestations. Summary-2

DrRobertFoxUtahSSF

More Related Content

What's hot (20)

Viewers also liked (11)

Similar to DrRobertFoxUtahSSF (20)

More from Flavio Guzmán (20)

Recently uploaded (20)

DrRobertFoxUtahSSF

Editor's Notes